Marc Martinez- Llordella

Marc Martinez- Llordella

Company: Quell Therapeutics, King’s College London

Job title: co-Founder & VP Biology, Visiting Lecturer


Treg-based Therapies to Induce Immune Tolerance in Transplantation & Autoimmunity 9:00 am

Lessons learned from Treg-directed therapies in liver transplantation (polyclonal Tregs vs low dose IL-2 therapy) Engineered Tregs for the modulation of antigen-specific responses Quell Therapeutics strategy to enhance Treg therapiesRead more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.